Samaha Eli
CIK 0001877589 Name as filed on the most recent filing
Filed as Samaha Eli (25)
54 transaction lines · from 25 filings · filed 2021-12-02 to 2026-07-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Theravance Biopharma, Inc. 4 filings
- ISSUER Stagwell Inc 6 filings
- ISSUER Synovus Financial Corp 10 filings
- ISSUER Pfsweb Inc 5 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
54 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-07 |
Theravance Biopharma, Inc. TBPH |
S, Open-market sale | 5,564 disposed | 17.17 | 95,540.56 | Form 4, filing 0001877589-26-000002 | |
| 2026-07-06 |
Theravance Biopharma, Inc. TBPH |
S, Open-market sale | 1,400 disposed | 17.04 | 23,856.00 | Form 4, filing 0001877589-26-000002 | |
| 2026-07-01 |
Theravance Biopharma, Inc. TBPH |
S, Open-market sale | 37,799 disposed | 17.00 | 642,628.36 | Form 4, filing 0001877589-26-000001 | |
| 2026-06-30 |
Theravance Biopharma, Inc. TBPH |
S, Open-market sale | 25,027 disposed | 17.13 | 428,787.59 | Form 4, filing 0001877589-26-000001 | |
| 2026-06-29 |
Theravance Biopharma, Inc. TBPH |
S, Open-market sale | 273,871 disposed | 17.23 | 4,720,139.30 | Form 4, filing 0001877589-26-000001 | |
| 2025-06-05 |
Stagwell Inc STGW |
P, Open-market purchase | 240,000 acquired | 4.43 | 1,063,200.00 | Form 4, filing 0001104659-25-057387 | |
| 2025-06-04 |
Stagwell Inc STGW |
P, Open-market purchase | 425,757 acquired | 4.27 | 1,817,982.39 | Form 4, filing 0001104659-25-057387 | |
| 2025-05-09 |
Stagwell Inc STGW |
P, Open-market purchase | 200,903 acquired | 4.76 | 956,318.37 | Form 4, filing 0001104659-25-047885 | |
| 2024-08-07 |
Theravance Biopharma, Inc. TBPH |
P, Open-market purchase | 999,800 acquired | 7.80 | 7,798,440.00 | Form 4, filing 0001877589-24-000006 | |
| 2024-06-10 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 172,889 disposed | 25.20 | 4,357,321.47 | Form 4, filing 0001877589-24-000005 | |
| 2024-06-07 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 20 disposed | 25.20 | 504.00 | Form 4, filing 0001877589-24-000004 | |
| 2024-06-06 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 325 disposed | 25.24 | 8,202.61 | Form 4, filing 0001877589-24-000004 | |
| 2024-06-05 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 6,803 disposed | 25.22 | 171,544.45 | Form 4, filing 0001877589-24-000004 | |
| 2024-06-04 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 6,278 disposed | 25.23 | 158,395.20 | Form 4, filing 0001877589-24-000003 | |
| 2024-06-03 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 13,685 disposed | 25.23 | 345,324.55 | Form 4, filing 0001877589-24-000003 | |
| 2024-05-31 |
Synovus Financial Corp SNVPRE |
S, Open-market sale | 200,000 disposed | 25.07 | 5,014,900.00 | Form 4, filing 0001877589-24-000003 | |
| 2024-05-01 |
Theravance Biopharma, Inc. TBPH |
P, Open-market purchase | 999,800 acquired | 8.75 | 8,748,250.00 | Form 4, filing 0001877589-24-000001 | |
| 2024-05-01 |
Theravance Biopharma, Inc. TBPH |
P, Open-market purchase | 499,324 acquired | 8.75 | 4,369,085.00 | Form 4, filing 0001877589-24-000001 | |
| 2023-10-20 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 560 acquired | 21.35 | 11,956.00 | Form 4, filing 0001877589-23-000008 | |
| 2023-10-13 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 4,279 acquired | 21.50 | 91,998.50 | Form 4, filing 0001877589-23-000007 | |
| 2023-10-12 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 235 acquired | 21.50 | 5,052.50 | Form 4, filing 0001877589-23-000007 | |
| 2023-10-11 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 881 acquired | 21.50 | 18,941.50 | Form 4, filing 0001877589-23-000006 | |
| 2023-10-10 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 1,072 acquired | 21.50 | 23,048.00 | Form 4, filing 0001877589-23-000006 | |
| 2023-10-09 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 957 acquired | 21.15 | 20,240.55 | Form 4, filing 0001877589-23-000006 | |
| 2023-10-02 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 3,466 acquired | 21.28 | 73,756.48 | Form 4, filing 0001877589-23-000005 | |
| 2023-09-27 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 12,196 acquired | 21.30 | 259,774.80 | Form 4, filing 0001877589-23-000004 | |
| 2023-09-26 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 9,633 acquired | 21.30 | 205,182.90 | Form 4, filing 0001877589-23-000003 | |
| 2023-09-25 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 7,553 acquired | 21.30 | 160,878.90 | Form 4, filing 0001877589-23-000003 | |
| 2023-09-22 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 9,036 acquired | 21.30 | 192,466.80 | Form 4, filing 0001877589-23-000003 | |
| 2023-09-21 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 8,884 acquired | 21.25 | 188,788.55 | Form 4, filing 0001877589-23-000002 | |
| 2023-09-20 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 36,425 acquired | 21.40 | 779,495.00 | Form 4, filing 0001877589-23-000002 | |
| 2023-09-19 |
Synovus Financial Corp SNVPRE |
P, Open-market purchase | 197,705 acquired | 21.40 | 4,230,333.43 | Form 4, filing 0001877589-23-000002 | |
| 2023-03-10 |
Stagwell Inc STGW |
P, Open-market purchase | 750,000 acquired | 6.75 | 5,062,500.00 | Form 4, filing 0001104659-23-032340 | |
| 2022-12-29 |
Pfsweb Inc PFSW |
S, Open-market sale | 883,000 disposed | 6.00 | 5,298,000.00 | Form 4, filing 0001877589-22-000007 | |
| 2022-12-29 |
Pfsweb Inc PFSW |
P, Open-market purchase | 883,000 acquired | 6.00 | 5,298,000.00 | Form 4, filing 0001877589-22-000007 | |
| 2022-12-28 |
Pfsweb Inc PFSW |
S, Open-market sale | 1,750,000 disposed | 5.92 | 10,360,000.00 | Form 4, filing 0001877589-22-000007 | |
| 2022-12-28 |
Pfsweb Inc PFSW |
P, Open-market purchase | 1,750,000 acquired | 5.92 | 10,360,000.00 | Form 4, filing 0001877589-22-000007 | |
| 2022-06-24 |
Pfsweb Inc PFSW |
P, Open-market purchase | 23,448 acquired | 11.72 | 274,810.56 | Form 4, filing 0001877589-22-000005 | |
| 2022-05-12 |
Stagwell Inc STGW |
P, Open-market purchase | 50,000 acquired | 6.90 | 344,790.00 | Form 4, filing 0001104659-22-059617 | |
| 2022-05-11 |
Stagwell Inc STGW |
P, Open-market purchase | 556,846 acquired | 6.91 | 3,849,197.98 | Form 4, filing 0001104659-22-059617 | |
| 2022-05-10 |
Stagwell Inc STGW |
P, Open-market purchase | 37,606 acquired | 6.79 | 255,450.04 | Form 4, filing 0001104659-22-059617 | |
| 2022-04-29 |
Pfsweb Inc PFSW |
P, Open-market purchase | 2,000 acquired | 11.24 | 22,480.00 | Form 4, filing 0001877589-22-000003 | |
| 2022-04-28 |
Pfsweb Inc PFSW |
P, Open-market purchase | 40,103 acquired | 11.25 | 451,158.75 | Form 4, filing 0001877589-22-000003 | |
| 2022-04-27 |
Pfsweb Inc PFSW |
P, Open-market purchase | 21,087 acquired | 11.19 | 235,963.53 | Form 4, filing 0001877589-22-000003 | |
| 2022-04-26 |
Pfsweb Inc PFSW |
P, Open-market purchase | 35,934 acquired | 11.13 | 399,945.42 | Form 4, filing 0001877589-22-000002 | |
| 2022-04-25 |
Pfsweb Inc PFSW |
P, Open-market purchase | 13,735 acquired | 11.18 | 153,557.30 | Form 4, filing 0001877589-22-000002 | |
| 2022-04-22 |
Pfsweb Inc PFSW |
P, Open-market purchase | 35,931 acquired | 11.15 | 400,630.65 | Form 4, filing 0001877589-22-000002 | |
| 2022-04-15 |
Pfsweb Inc PFSW |
P, Open-market purchase | 6,200 acquired | 12.00 | 74,400.00 | Form 4, filing 0001877589-22-000004 | |
| 2022-04-14 |
Pfsweb Inc PFSW |
P, Open-market purchase | 7,307 acquired | 11.62 | 84,907.34 | Form 4, filing 0001877589-22-000004 | |
| 2021-12-06 |
Stagwell Inc STGW |
P, Open-market purchase | 290,296 acquired | 8.14 | 2,363,009.44 | Form 4, filing 0001104659-21-147255 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 40
- Open-market sale 14
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Samaha Eli, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001877589
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6